TY - JOUR
T1 - Novel Metformin Indications and Skin Disorders
AU - Hussein, Ramadan S.
AU - Abdelbasset, Walid Kamal
AU - Mahfouz, Osama
N1 - Publisher Copyright:
© 2022, International Medical Research and Development Corporation. All rights reserved.
PY - 2022/12
Y1 - 2022/12
N2 - Metformin is the first-line medication to increase insulin sensitivity in insulin-resistant conditions such as type 2 diabetes, polycystic ovary syndrome, and obesity. However, metformin is a drug with a wide range of pharmacological properties, showing the ability to treat various skin conditions. Some inflammatory skin dermatoses, skin neoplasms, endocrinology-related dermatosis, pigmentary disorders, skin aging, and wound healing have all shown improvement when metformin is used. This review discusses the most recent research supporting the use of metformin as a treatment for common skin conditions.(International Journal of Biomedicine. 2022;12(4):521-525.).
AB - Metformin is the first-line medication to increase insulin sensitivity in insulin-resistant conditions such as type 2 diabetes, polycystic ovary syndrome, and obesity. However, metformin is a drug with a wide range of pharmacological properties, showing the ability to treat various skin conditions. Some inflammatory skin dermatoses, skin neoplasms, endocrinology-related dermatosis, pigmentary disorders, skin aging, and wound healing have all shown improvement when metformin is used. This review discusses the most recent research supporting the use of metformin as a treatment for common skin conditions.(International Journal of Biomedicine. 2022;12(4):521-525.).
KW - indications
KW - Metformin
KW - skin disorders
UR - http://www.scopus.com/inward/record.url?scp=85143486965&partnerID=8YFLogxK
U2 - 10.21103/Article12(4)_RA4
DO - 10.21103/Article12(4)_RA4
M3 - Review article
AN - SCOPUS:85143486965
SN - 2158-0510
VL - 12
SP - 521
EP - 525
JO - International Journal of Biomedicine
JF - International Journal of Biomedicine
IS - 4
ER -
